Medicamen Biotech Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
MEDICAMEQ · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Medicamen Biotech has informed the exchanges that its trading window will be closed from July 1, 2025, until 48 hours after the declaration of its unaudited financial results (both standalone and consolidated) for the quarter ended June 30, 2025. This closure applies to all directors, designated persons, and connected persons under the company's insider trading code, prohibiting them from trading in the company's shares during this period. The date of the board meeting to approve the Q1 FY26 results will be communicated separately. This is a standard compliance filing under SEBI's Prohibition of Insider Trading Regulations, 2015.
This is a routine regulatory filing with no direct impact on the stock price. However, it signals that the company's Q1 FY26 results are imminent, which investors should watch for as the next potential catalyst.